GALNT13 antibody
Principal name
GALNT13 antibody
Alternative names for GALNT13 antibody
GalNAc transferase 13, KIAA1918, pp-GaNTase 13, GalNAc-T13, Polypeptide N-acetylgalactosaminyltransferase 13, Protein-UDP acetylgalactosaminyltransferase 13, UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 13
Ncbi ID
9606, NP_443149, NM_052917, NP_443149.2, NP_954537.1, NM_173030
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection))
Background of GALNT13 antibody
- Kit Component:
- - KN216821G1, GALNT13 gRNA vector 1 in pCas-Guide vector
- KN216821G2, GALNT13 gRNA vector 2 in pCas-Guide vector
- KN216821D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Hillier,L.W., (2005) Nature 434 (7034), 724-731

Western Blot analysis of GALNT13 expression in transfected 293T cell line by GALNT13 MaxPab polyclonal antibody.Lane 1: GALNT13 transfected lysate(61.16 KDa).Lane 2: Non-transfected lysate.

Human HeLa; WB Suggested Anti-GALNT13 Antibody Titration: 0.2-1 ug/ml. Positive Control: Hela cell lysate; GALNT13 antibody - N-terminal region (ARP50222_P050) in Human HeLa cells using Western Blot
Lysates
| Catalog No. | ||
|---|---|---|
| LY409395 | GALNT13 overexpression lysate |
|
![]() |
0.1 mg /
$295.00
|
|
| OriGene Technologies, Inc. |



